EMEA-000371-PIP01-08

  • Email
  • Help

Overview

Product details for Revlimid
Invented nameRevlimid
Active substance

Lenalidomide

Decision numberP/102/2008
PIP numberEMEA-000371-PIP01-08
Pharmaceutical form(s)Hard capsule
Condition(s)/indication(s)

Myelodysplastic Syndrome

Route(s) of administrationOral use
PIP applicant

Applicant: Celgene Europe Limited
E-mail: medinfo.intl@celgene.com
Country: Switzerland
Phone: +41 327298500
Fax: +41 327298508

Decision typeW: decision granting a waiver in all age groups for the listed condition(s)

Decision